Want to join the conversation?
$EL 4Q15 Call: Results excludes YoverY impact of restructuring & Venezuela remeasurement charges, also excluded impact of acceleration of retailer orders that otherwise would have occurred in 1Q15 related to our July 2014 rollout of SMI. Impact of that shift was $178MM in sales & $127MM in operating income equal to approx. $0.21 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?